BIOMAT Database Logo BIOMAT Database Logo

Nitric oxide mediates angiogenesis induced in vivo by platelet-activating factor and tumor necrosis factor-alpha. 1997

G Montrucchio, and E Lupia, and A de Martino, and E Battaglia, and M Arese, and A Tizzani, and F Bussolino, and G Camussi
Dipartimento di Fisiopatologia Clinica, Università di Torino, Italy.

We evaluated the role of an endogenous production of nitric oxide (NO) in the in vitro migration of endothelial cells and in the in vivo angiogenic response elicited by platelet-activating factor (PAF), tumor necrosis factor-alpha (TNF), and basic fibroblast growth factor (bFGF). The NO synthase inhibitor, N omega-nitro-L-arginine-methyl ester (L-NAME), but not its enantiomer D-NAME, prevented chemotaxis of endothelial cells induced in vitro by PAF and by TNF. The motogenic activity of TNF was also inhibited by WEB 2170, a specific PAF-receptor antagonist. In contrast, chemotaxis induced by bFGF was not prevented by L-NAME or by WEB 2170. Angiogenesis was studied in vivo in a murine model in which Matrigel was used as a vehicle for the delivery of mediators. In this model, the angiogenesis induced by PAF and TNF was inhibited by WEB 2170 and L-NAME but not by D-NAME. In contrast, angiogenesis induced by bFGF was not affected by L-NAME or by WEB 2170. TNF, but not bFGF, induced PAF synthesis within Matrigel. These results suggest that NO mediates the angiogenesis induced by PAF as well as that induced by TNF, which is dependent on the production of PAF. In contrast, the angiogenic effect of bFGF appears to be both PAF and NO independent.

UI MeSH Term Description Entries
D008810 Mice, Inbred C57BL One of the first INBRED MOUSE STRAINS to be sequenced. This strain is commonly used as genetic background for transgenic mouse models. Refractory to many tumors, this strain is also preferred model for studying role of genetic variations in development of diseases. Mice, C57BL,Mouse, C57BL,Mouse, Inbred C57BL,C57BL Mice,C57BL Mice, Inbred,C57BL Mouse,C57BL Mouse, Inbred,Inbred C57BL Mice,Inbred C57BL Mouse
D009569 Nitric Oxide A free radical gas produced endogenously by a variety of mammalian cells, synthesized from ARGININE by NITRIC OXIDE SYNTHASE. Nitric oxide is one of the ENDOTHELIUM-DEPENDENT RELAXING FACTORS released by the vascular endothelium and mediates VASODILATION. It also inhibits platelet aggregation, induces disaggregation of aggregated platelets, and inhibits platelet adhesion to the vascular endothelium. Nitric oxide activates cytosolic GUANYLATE CYCLASE and thus elevates intracellular levels of CYCLIC GMP. Endogenous Nitrate Vasodilator,Mononitrogen Monoxide,Nitric Oxide, Endothelium-Derived,Nitrogen Monoxide,Endothelium-Derived Nitric Oxide,Monoxide, Mononitrogen,Monoxide, Nitrogen,Nitrate Vasodilator, Endogenous,Nitric Oxide, Endothelium Derived,Oxide, Nitric,Vasodilator, Endogenous Nitrate
D010972 Platelet Activating Factor A phospholipid derivative formed by PLATELETS; BASOPHILS; NEUTROPHILS; MONOCYTES; and MACROPHAGES. It is a potent platelet aggregating agent and inducer of systemic anaphylactic symptoms, including HYPOTENSION; THROMBOCYTOPENIA; NEUTROPENIA; and BRONCHOCONSTRICTION. AGEPC,Acetyl Glyceryl Ether Phosphorylcholine,PAF-Acether,Phosphorylcholine, Acetyl Glyceryl Ether,1-Alkyl-2-acetyl-sn-glycerophosphocholine,Platelet Aggregating Factor,Platelet Aggregation Enhancing Factor,Platelet-Activating Substance,Thrombocyte Aggregating Activity,1 Alkyl 2 acetyl sn glycerophosphocholine,Aggregating Factor, Platelet,Factor, Platelet Activating,PAF Acether,Platelet Activating Substance
D002465 Cell Movement The movement of cells from one location to another. Distinguish from CYTOKINESIS which is the process of dividing the CYTOPLASM of a cell. Cell Migration,Locomotion, Cell,Migration, Cell,Motility, Cell,Movement, Cell,Cell Locomotion,Cell Motility,Cell Movements,Movements, Cell
D004730 Endothelium, Vascular Single pavement layer of cells which line the luminal surface of the entire vascular system and regulate the transport of macromolecules and blood components. Capillary Endothelium,Vascular Endothelium,Capillary Endotheliums,Endothelium, Capillary,Endotheliums, Capillary,Endotheliums, Vascular,Vascular Endotheliums
D004791 Enzyme Inhibitors Compounds or agents that combine with an enzyme in such a manner as to prevent the normal substrate-enzyme combination and the catalytic reaction. Enzyme Inhibitor,Inhibitor, Enzyme,Inhibitors, Enzyme
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D001381 Azepines Seven membered heterocyclic rings containing a NITROGEN atom. Hexamethyleneimines

Related Publications

G Montrucchio, and E Lupia, and A de Martino, and E Battaglia, and M Arese, and A Tizzani, and F Bussolino, and G Camussi
Tumor necrosis factor-alpha mediates endotoxin-induced lung injury in platelet activating factor-primed rats.
December 1993, The Journal of pharmacology and experimental therapeutics,
G Montrucchio, and E Lupia, and A de Martino, and E Battaglia, and M Arese, and A Tizzani, and F Bussolino, and G Camussi
Nitric oxide mediates tumor necrosis factor-alpha cytotoxicity in endothelial cells.
July 1992, Biochemical and biophysical research communications,
G Montrucchio, and E Lupia, and A de Martino, and E Battaglia, and M Arese, and A Tizzani, and F Bussolino, and G Camussi
Role of nitric oxide and platelet-activating factor in cardiac alterations induced by tumor necrosis factor-alpha in the guinea-pig papillary muscle.
March 1999, Cardiovascular research,
G Montrucchio, and E Lupia, and A de Martino, and E Battaglia, and M Arese, and A Tizzani, and F Bussolino, and G Camussi
Nitric oxide mediates platelet activating factor-induced microvascular leakage in rat airways.
January 2001, The Annals of otology, rhinology, and laryngology,
G Montrucchio, and E Lupia, and A de Martino, and E Battaglia, and M Arese, and A Tizzani, and F Bussolino, and G Camussi
Nitric oxide mediates down regulation of lipoprotein lipase activity induced by tumor necrosis factor-alpha in brown adipocytes.
September 1997, European journal of pharmacology,
G Montrucchio, and E Lupia, and A de Martino, and E Battaglia, and M Arese, and A Tizzani, and F Bussolino, and G Camussi
Nitric oxide mediates the inhibitory action of platelet-activating factor on angiotensin II-induced renal vasoconstriction, in vivo.
June 1996, The Journal of pharmacology and experimental therapeutics,
G Montrucchio, and E Lupia, and A de Martino, and E Battaglia, and M Arese, and A Tizzani, and F Bussolino, and G Camussi
Roles of nitric oxide synthases in platelet-activating factor-induced intestinal necrosis in rats.
February 1999, Critical care medicine,
G Montrucchio, and E Lupia, and A de Martino, and E Battaglia, and M Arese, and A Tizzani, and F Bussolino, and G Camussi
Bowel necrosis induced by tumor necrosis factor in rats is mediated by platelet-activating factor.
May 1988, The Journal of clinical investigation,
G Montrucchio, and E Lupia, and A de Martino, and E Battaglia, and M Arese, and A Tizzani, and F Bussolino, and G Camussi
Tumor necrosis factor-alpha-induced activating protein-1 activity is modulated by nitric oxide-mediated protein kinase G activation.
January 2000, American journal of respiratory cell and molecular biology,
G Montrucchio, and E Lupia, and A de Martino, and E Battaglia, and M Arese, and A Tizzani, and F Bussolino, and G Camussi
Nitric oxide mediates the inhibitory effect of tumor necrosis factor-alpha on prolactin release.
August 2001, Neuroendocrinology,
Copied contents to your clipboard!